Catalent to provide development and anal…

The University of Nebraska Medical Center (UNMC), a state agency within the University of Nebraska system, awarded a purchase order valued at $165,950 to Catalent Pharma Solutions, LLC, a pharmaceutical services vendor headquartered in Morrisville, North Carolina. The contract was executed on May 5, 2026, with an award date of May 11, 2026, and is designated as Purchase Order Number 4900004681. The period of performance extends from May 11, 2026, through July 31, 2026, with a final delivery date of July 31, 2026.

Under this purchase order, Catalent Pharma Solutions, LLC is obligated to provide development and analytical services for the University of Nebraska Medical Center. The place of performance is identified as the UNMC Durham Research Center located in Omaha, Nebraska. Delivery terms are established as Free on Board (F.O.B.) destination with freight prepaid, and payment is structured on a Net 30 basis. The contract is governed by the Standard Terms of Purchase of the University of Nebraska unless superseded by a separate agreement between the vendor and the Board of Regents.